Community Research and Development Information Service - CORDIS

NANOMED TAB Round 3 begins, apply now for the first European Mentoring Force Accelerator in Nanomedicine

Contributed by: VDI/VDE-IT

The ENATRANS project is pleased to announce that Round 3 of applications to the Nanomedicine Translation Advisory Board (Nanomed TAB) is now open to companies, public and private research entities, and other organisations leading Nanomedicine projects in Europe.
Last year, the EU-funded consortium ENATRANS (Enabling NAnomedicine TRANSlation) launched the Nanomed TAB, the first European mentoring force accelerator in Nanomedicine sponsored by the European Commission to provide high level support to ambitious innovative European Nanomedicine projects.

The TAB offers a free of charge mentoring service to fast-track promising projects to the market, based on the high-level experience of seasoned Pharma/Biotech translation experts

During its two first successful rounds, the TAB has received a total of 42 applications from 15 countries in Europe and EU associated countries. Around half of them have been selected and are currently benefiting from mentoring and follow up over time. In parallel new additions to the pool of experts aim at increasing the TAB's capacity to call for more applications.

Deadline for applications in Round 3 is the 31 July 2016.

Selected projects will be invited to attend the 3rd TAB-In Sessions, a series of individual meetings with experts to be held on14 October 2016, in Heraklion, Crete (Greece), in the framework of the ETPN Annual Event.

Applications should be submitted through the following link:



Related information


Countries (34)

  • Austria, Bosnia and Herzegovina, Belgium, Bulgaria, Switzerland, Cyprus, Czech Republic, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Croatia, Hungary, Ireland, Israel, Iceland, Italy, Lithuania, Luxembourg, Latvia, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Sweden, Slovenia, Slovakia, Turkey, United Kingdom


Nanomedicine, Nanobiomedical, experts advice, translation
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top